510(k) · Cleared
Recalled · 2011Celsite/ Celsite Concept, Access Ports
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Aesculap, Inc. · LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Cleared on Jul 31, 2006 as substantially equivalent to K902401 (Burron Medical, Inc., 1991) and 7 other predicates after a 69-day review. Its family tree reaches back 2 generations to 1995. 1 later device descends from it. It has been recalled 2 times.
- Decided
- Jul 31, 2006
- Review
- 69 days
- Class
- Class II
- Product code
- LJT
- Recalls
- 2
- Predicates
- 8
Its longest line of descent runs back 2 generations to K952548 (1995). 13 ancestors in all, the oldest K830730 (1983). 1 later device descends from it, 1 citing it directly.
- Root · 2 generations backK952548 Celsite Venous SystemB.Braun Medical, Inc. · 1995 · Recalled
- 1 generation backK962230 Celsite Port with Preconnected CatheterB.Braun Medical, Inc. · 1996 · Recalled
- This deviceK061424 Celsite/ Celsite Concept, Access PortsAesculap, Inc. · 2006
- Descendant · cites it directly · 0 of its ownK130576 Celsite Implantable Access Port SystemsB. Braun Interventional Systems, Inc. · 2013 · Recalled
Most influential descendants
Showing 1 of 1 · See all- K130576Celsite Implantable Access Port SystemsB. Braun Interventional Systems, Inc. · 2013 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K952548 | Celsite Venous System | B.Braun Medical, Inc. | 1995 | 2 |
| −1 | K962230 | Celsite Port with Preconnected Catheter | B.Braun Medical, Inc. | 1996 | 1 |
| 0 (this device) | K061424 | Celsite/ Celsite Concept, Access Ports | Aesculap, Inc. | 2006 | — |
| +1 | K130576 | Celsite Implantable Access Port Systems | B. Braun Interventional Systems, Inc. | 2013 | 2 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1983 | 1 | 0 |
| 1991 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2003 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LJT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LJT device
- #1 K251253 PowerPort™ isp Implantable Port; PowerPort™…score 14.9 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (8)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K902401 | Celsite (TM) Implantable Drug Delivery SystemSummary page 1…Aesculap®, Inc. believes that the Celsite®/ Celsite® Concept TM Access Ports are substantially equivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsit… | 1991 |
| * | K952548 | Celsite Venous SystemSummary page 1…®, Inc. believes that the Celsite®/ Celsite® Concept TM Access Ports are substantially equivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsite®/ Celsi… | 1995 |
| * | K954297 | Celsite Venous Access System OtwSummary page 1…elieves that the Celsite®/ Celsite® Concept TM Access Ports are substantially equivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsite®/ Celsite® Conce… | 1995 |
| * | K962230 | Celsite Port with Preconnected CatheterSummary page 1…hat the Celsite®/ Celsite® Concept TM Access Ports are substantially equivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsite®/ Celsite® Concept Tm Acc… | 1996 |
| * | K993024 | Celsite Implantable Port with Valved CatheterSummary page 1…elsite®/ Celsite® Concept TM Access Ports are substantially equivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsite®/ Celsite® Concept Tm Access Ports… | 2000 |
| * | K032557 | Triumph VTX with Lifevalve CatheterSummary page 1…re substantially equivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsite®/ Celsite® Concept Tm Access Ports are an implantable port and catheter syste… | 2003 |
| * | K992697 | Port-a-Cath II Trans-Arterial Percutaneous SystemSummary page 1…ntially equivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsite®/ Celsite® Concept Tm Access Ports are an implantable port and catheter system which a… | 1999 |
| * | K932840 | Port-a-Cath Implantable Vascular Access SystemSummary page 1…quivalent to Aesculap's currently marketed Celsite® Access Port Systems (K902401, K952548, K954297, K962230, K993024) and Deltec Inc., PORT-A-CATH® II (K032557, K992697, K932840). DEVICE DESCRIPTION The Celsite®/ Celsite® Concept Tm Access Ports are an implantable port and catheter system which allows saf… | 1994 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K130576 | Celsite Implantable Access Port Systems | 2013 | 0 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Apr 13, 2011 | Not classified | Z-2671-2011 | Process design | The affected products contain the incorrect winged Surecan needle accessory component in certain Celsite Access Port package configurations. The winged Surecan needle is used to deliver medications and fluids into implanted Celsite Access… |
| Jun 22, 2009 | Not classified | Z-1961-2009 | Nonconforming Material/Component | B. Braun Interventional Systems was notified by B. Braun Medical France, the manufacturer of the Celsite Access port that they had received 11 reports of polyurethane (type P) catheter disconnections. B. Braun Medical France has decided… |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 11 years and passes through 2 companies; a new generation was cleared every 9.6 years on median.
- 9 of the 13 ancestors have a recall of any class.
- Of its descendants, K130576 (B. Braun Interventional Systems, Inc., 2013) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K902401.
How does its category compare?
All LJT devicesLJT Port & Catheter, Implanted, Subcutaneous, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LJT
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LJT
182in 2016
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LJT
1in 2022
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · LJT
4,308in 2025
MAUDE reports naming product code LJT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 11 | 85 | 1 | 208 |
| 2008 | 7 | 119 | 2 | 161 |
| 2009 | 2 | — | 2 | 172 |
| 2010 | 2 | — | 19 | 207 |
| 2011 | 5 | 144 | 1 | 202 |
| 2012 | 2 | — | 2 | 153 |
| 2013 | 7 | 150 | 0 | 141 |
| 2014 | 2 | — | 0 | 143 |
| 2015 | 4 | 164 | 1 | 149 |
| 2016 | 3 | 182 | 0 | 135 |
| 2017 | 0 | — | 1 | 262 |
| 2018 | 0 | — | 1 | 878 |
| 2019 | 1 | — | 7 | 765 |
| 2020 | 1 | — | 0 | 959 |
| 2021 | 0 | — | 0 | 1,285 |
| 2022 | 0 | — | 1 | 1,334 |
| 2023 | 1 | — | 0 | 1,221 |
| 2024 | 1 | — | 0 | 1,896 |
| 2025 | 2 | — | 0 | 4,308 |
| 2026 | 1 | — | 1 (1) | — |
What is it indicated for?
The Aesculap Celsite®/Celsite® Concept' Access Ports are indicated for intra-venous administration of drugs for chemotherapy, antibiotics and anti-viral drugs, and for parenteral nutrition, blood sampling or transfusions.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K061424 · printed Nov 6, 2026
Cite this page
510(k) Report. “K061424: Celsite/ Celsite Concept, Access Ports.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K061424
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026